Literature DB >> 15929983

Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the nicotinic acetylcholine receptor.

Sébastien Dutertre1, Annette Nicke, Richard J Lewis.   

Abstract

The structures of acetylcholine-binding protein (AChBP) and nicotinic acetylcholine receptor (nAChR) homology models have been used to interpret data from mutagenesis experiments at the nAChR. However, little is known about AChBP-derived structures as predictive tools. Molecular surface analysis of nAChR models has revealed a conserved cleft as the likely binding site for the 4/7 alpha-conotoxins. Here, we used an alpha3beta2 model to identify beta2 subunit residues in this cleft and investigated their influence on the binding of alpha-conotoxins MII, PnIA, and GID to the alpha3beta2 nAChR by two-electrode voltage clamp analysis. Although a beta2-L119Q mutation strongly reduced the affinity of all three alpha-conotoxins, beta2-F117A, beta2-V109A, and beta2-V109G mutations selectively enhanced the binding of MII and GID. An increased activity of alpha-conotoxins GID and MII was also observed when the beta2-F117A mutant was combined with the alpha4 instead of the alpha3 subunit. Investigation of A10L-PnIA indicated that high affinity binding to beta2-F117A, beta2-V109A, and beta2-V109G mutants was conferred by amino acids with a long side chain in position 10 (PnIA numbering). Docking simulations of 4/7 alpha-conotoxin binding to the alpha3beta2 model supported a direct interaction between mutated nAChR residues and alpha-conotoxin residues 6, 7, and 10. Taken together, these data provide evidence that the beta subunit contributes to alpha-conotoxin binding and selectivity and demonstrate that a small cleft leading to the agonist binding site is targeted by alpha-conotoxins to block the nAChR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929983     DOI: 10.1074/jbc.M504229200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Ching-I A Wang; Markus Muttenthaler; Paul F Alewood; Richard J Lewis; David J Adams
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

2.  Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Miguel Ruiz; Mick'l Scadden; Sean Christensen; Joanna Gajewiak; Layla Azam; J Michael McIntosh
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

3.  Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Hartmut Cuny; Andrew Hung; Richard J Clark; Andreas Brust; Kalyana Akondi; Paul F Alewood; David J Craik; David J Adams
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

Review 4.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

Review 5.  Use of venom peptides to probe ion channel structure and function.

Authors:  Sébastien Dutertre; Richard J Lewis
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

6.  Key residues in the nicotinic acetylcholine receptor β2 subunit contribute to α-conotoxin LvIA binding.

Authors:  Dongting Zhangsun; Xiaopeng Zhu; Yong Wu; Yuanyan Hu; Quentin Kaas; David J Craik; J Michael McIntosh; Sulan Luo
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

Review 7.  α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Authors:  Hartmut Cuny; Rilei Yu; Han-Shen Tae; Shiva N Kompella; David J Adams
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

8.  Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.

Authors:  Todd T Talley; Baldomero M Olivera; Kyou-Hoon Han; Sean B Christensen; Cheryl Dowell; Igor Tsigelny; Kwok-Yiu Ho; Palmer Taylor; J Michael McIntosh
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

9.  Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.

Authors:  Reena Halai; Richard J Clark; Simon T Nevin; Jonas E Jensen; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

Review 10.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.